2018 Constipation Drug Development Pipeline Analysis - ResearchAndMarkets.com

DUBLIN--()--The "2018 Constipation Drug Development- Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering.

With an estimated $20 billion market value, constipation is one of the most common gastrointestinal conditions, presenting robust opportunities for development of treatment options. In addition to hard bowel moment, other symptoms of constipation include bloating and abdominal pain.

Over 50 companies and universities are focusing on developing treatment options for Constipation.

This report provides insights into different therapeutic candidates in preclinical, research, discovery, NDA/IND, pre registration, phase 1, phase 2, and phase 3 trials). Drugs under development directly and through combination with other drugs are also included.

Current status, developmental phase, participating companies and entities, recent developments, orphan drug/ fast track/ other designations, drug class are provided for each Constipation pipeline product. Mechanism of Action and the target area of the pipeline product are also provided. Further, clinical and preclinical trials along with results of the trials are also included in the report.

In addition to complete details of each product, the report provides key trends in Constipation pipeline studies. The products under development are categorized according to their development phase, mechanism and company to provide detailed insights into the type of drugs being developed and the stages of development.

Companies Mentioned

  • Ache Laboratories
  • Allergan
  • Ardelyx Inc
  • BioGaia
  • Braintree Laboratories Inc
  • Dong-A ST Co Ltd
  • EA Pharma Co Ltd
  • Enterin Inc
  • Ironwood Pharmaceuticals Inc
  • Mallinckrodt
  • NGM Biopharmaceuticals
  • Nordic Life Science Pipeline
  • RaQualia Pharma
  • Renexxion LLC
  • Shire-Movetis N.V.
  • SK Biopharmaceuticals
  • Sumitomo Dainippon Pharma Co Ltd
  • Synergy Pharmaceuticals
  • Synthetic Biologics
  • Tsumura
  • Vanda Pharmaceuticals
  • Yuhan

Key Topics Covered

1 Table of Contents

2 Constipation Pipeline Analysis

3 Constipation - Company-wise Pipeline Analysis

4 Constipation R&D Pipeline Snapshots

5 Recent Developments in Constipation Pipeline

For more information about this report visit https://www.researchandmarkets.com/research/pkk4m5/2018_constipation?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Gastrointestinal Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery, Gastrointestinal Drugs